La Salle St. Investment Advisors, LLC Astrazeneca PLC Transaction History
La Salle St. Investment Advisors, LLC
- $558 Million
- Q3 2025
A detailed history of La Salle St. Investment Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, La Salle St. Investment Advisors, LLC holds 5,158 shares of AZN stock, worth $461,125. This represents 0.07% of its overall portfolio holdings.
Number of Shares
5,158
Previous 5,309
2.84%
Holding current value
$461,125
Previous $371,000
6.47%
% of portfolio
0.07%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,521Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...